Clinical Trial Update: A Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of a genetically targeted enzyme replacement therapy for advanced heart failure has completed, per the trial update from Celladon Corpora…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Heart Failure
• Ischemic Cardiomyopathy
• Non-ischemic Cardiomyopathy

Drugs mentioned

• Genetically Targeted Enzyme Replacement Therapy

Snippet

Sponsor: Celladon Corporation | Conditions: Ischemic Cardiomyopathy, Non-ischemic Cardiomyopathy | Phase 2 | Status: COMPLETED